• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病例报告:一个中国家庭中的两例遗传性血管性水肿。

Case Report: Two cases of hereditary angioedema in a Chinese family.

作者信息

Guo Yuanli, Qi Manli, Ding Jinluan

机构信息

Department of Dermatology, Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University, Tianjin, China.

出版信息

Front Allergy. 2025 Jun 2;6:1587904. doi: 10.3389/falgy.2025.1587904. eCollection 2025.

DOI:10.3389/falgy.2025.1587904
PMID:40529569
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12171423/
Abstract

BACKGROUND

Hereditary angioedema (HAE) is a life-threatening condition characterized by repeated asymmetric cutaneous and mucosal edema. It is a rare autosomal dominant genetic disease with a mortality rate of 8.6%. Family survey of HAE in China is seldom reported since it is still under recognized.

CASE REPORT

We reported two cases of HAE and a family survey conducted in Hebei Province, China. The proband was a woman who had edema for over 7 years. She was diagnosed with type I HAE in her 50s after a life-threatening asphyxia attack. Her elder brother was initially diagnosed with mild symptoms.

CONCLUSION

Two diagnosed and three suspected patients were identified in our family survey. Family surveys are important method for identifying asymptomatic patients and preventing attacks. It is valuable for rescuing people from sudden death, particularly from asphyxia.

摘要

背景

遗传性血管性水肿(HAE)是一种危及生命的疾病,其特征为反复出现不对称性皮肤和黏膜水肿。它是一种罕见的常染色体显性遗传病,死亡率为8.6%。由于在中国HAE仍未得到充分认识,因此关于HAE的家族调查鲜有报道。

病例报告

我们报告了两例HAE病例以及在中国河北省进行的一次家族调查。先证者为一名有7年以上水肿病史的女性。她在50多岁时因一次危及生命的窒息发作后被诊断为I型HAE。她的哥哥最初被诊断为症状较轻。

结论

在我们的家族调查中确定了两名确诊患者和三名疑似患者。家族调查是识别无症状患者和预防发作的重要方法。对于挽救突发死亡尤其是窒息死亡的患者具有重要价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b6d/12171423/4719e9ea49af/falgy-06-1587904-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b6d/12171423/f33a5967a0ac/falgy-06-1587904-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b6d/12171423/4719e9ea49af/falgy-06-1587904-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b6d/12171423/f33a5967a0ac/falgy-06-1587904-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b6d/12171423/4719e9ea49af/falgy-06-1587904-g002.jpg

相似文献

1
Case Report: Two cases of hereditary angioedema in a Chinese family.病例报告:一个中国家庭中的两例遗传性血管性水肿。
Front Allergy. 2025 Jun 2;6:1587904. doi: 10.3389/falgy.2025.1587904. eCollection 2025.
2
Adapting Safety Plans for Autistic Adults with Involvement from the Autism Community.在自闭症群体的参与下为成年自闭症患者调整安全计划。
Autism Adulthood. 2025 May 28;7(3):293-302. doi: 10.1089/aut.2023.0124. eCollection 2025 Jun.
3
Interventions for central serous chorioretinopathy: a network meta-analysis.中心性浆液性脉络膜视网膜病变的干预措施:一项网状Meta分析
Cochrane Database Syst Rev. 2025 Jun 16;6(6):CD011841. doi: 10.1002/14651858.CD011841.pub3.
4
Aural toilet (ear cleaning) for chronic suppurative otitis media.慢性化脓性中耳炎的耳道清理(耳部清洁)
Cochrane Database Syst Rev. 2025 Jun 9;6(6):CD013057. doi: 10.1002/14651858.CD013057.pub3.
5
Electronic cigarettes for smoking cessation.用于戒烟的电子烟。
Cochrane Database Syst Rev. 2025 Jan 29;1(1):CD010216. doi: 10.1002/14651858.CD010216.pub9.
6
Systemic antibiotics for chronic suppurative otitis media.用于慢性化脓性中耳炎的全身性抗生素
Cochrane Database Syst Rev. 2025 Jun 9;6(6):CD013052. doi: 10.1002/14651858.CD013052.pub3.
7
Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology.不明病因复发性流产女性预防流产的孕激素治疗
Cochrane Database Syst Rev. 2025 Jun 11;6(6):CD003511. doi: 10.1002/14651858.CD003511.pub6.
8
Surveillance for Violent Deaths - National Violent Death Reporting System, 50 States, the District of Columbia, and Puerto Rico, 2022.暴力死亡监测——2022年全国暴力死亡报告系统,50个州、哥伦比亚特区和波多黎各
MMWR Surveill Summ. 2025 Jun 12;74(5):1-42. doi: 10.15585/mmwr.ss7405a1.
9
Stem cell injections for osteoarthritis of the knee.用于膝关节骨关节炎的干细胞注射
Cochrane Database Syst Rev. 2025 Apr 2;4(4):CD013342. doi: 10.1002/14651858.CD013342.pub2.
10
Caesarean myomectomy in pregnant women with uterine fibroids.患有子宫肌瘤的孕妇行剖宫产肌瘤切除术
Cochrane Database Syst Rev. 2025 Jan 27;1(1):CD016119. doi: 10.1002/14651858.CD016119.

本文引用的文献

1
Initial Experience of Long-Term Prophylaxis with Lanadelumab for Hereditary Angioedema in China: A Clinical Observation Study on Six Patients.在中国使用兰那度单抗长期预防遗传性血管性水肿的初步经验:6例患者的临床观察研究
Int Arch Allergy Immunol. 2025;186(3):221-231. doi: 10.1159/000541242. Epub 2024 Oct 3.
2
A comprehensive review on the current status of CRISPR based clinical trials for rare diseases.基于 CRISPR 的罕见病临床试验现状的全面综述。
Int J Biol Macromol. 2024 Oct;277(Pt 2):134097. doi: 10.1016/j.ijbiomac.2024.134097. Epub 2024 Jul 25.
3
Plasminogen missense variants and their involvement in cardiovascular and inflammatory disease.
纤溶酶原错义变体及其与心血管和炎症性疾病的关联。
Front Cardiovasc Med. 2024 Jun 25;11:1406953. doi: 10.3389/fcvm.2024.1406953. eCollection 2024.
4
Epidemiology, economic, and humanistic burden of hereditary angioedema: a systematic review.遗传性血管性水肿的流行病学、经济学和人文负担:系统评价。
Orphanet J Rare Dis. 2024 Jul 8;19(1):256. doi: 10.1186/s13023-024-03265-z.
5
Contact System Activation and Bradykinin Generation in Angioedema: Laboratory Assessment and Biomarker Utilization.接触系统激活与缓激肽生成在血管性水肿中的作用:实验室评估与生物标志物应用。
Immunol Allergy Clin North Am. 2024 Aug;44(3):543-560. doi: 10.1016/j.iac.2024.03.011. Epub 2024 May 18.
6
Transmission patterns of C1-INH deficiency hereditary angioedema favors a wild-type male offspring: Our experience at Chandigarh, India.C1-INH 缺乏性遗传性血管性水肿的传播模式有利于野生型男性后代:来自印度昌迪加尔的经验。
Immunobiology. 2024 Mar;229(2):152790. doi: 10.1016/j.imbio.2024.152790. Epub 2024 Feb 6.
7
Hereditary Angioedema: Diagnosis, Clinical Implications, and Pathophysiology.遗传性血管性水肿:诊断、临床意义和病理生理学。
Adv Ther. 2023 Mar;40(3):814-827. doi: 10.1007/s12325-022-02401-0. Epub 2023 Jan 7.
8
The international WAO/EAACI guideline for the management of hereditary angioedema - The 2021 revision and update.国际血管性水肿学会(WAO)/欧洲变态反应和临床免疫学会(EAACI)遗传性血管性水肿管理指南——2021年修订与更新
World Allergy Organ J. 2022 Apr 7;15(3):100627. doi: 10.1016/j.waojou.2022.100627. eCollection 2022 Mar.
9
The prevalence of hereditary angioedema in a Chinese cohort with decreased complement 4 levels.中国补体4水平降低队列中遗传性血管性水肿的患病率。
World Allergy Organ J. 2021 Dec 18;15(1):100620. doi: 10.1016/j.waojou.2021.100620. eCollection 2022 Jan.
10
Lanadelumab Efficacy, Safety, and Injection Interval Extension in HAE: A Real-Life Study.拉那芦单抗治疗遗传性血管性水肿的疗效、安全性和注射间隔延长:真实世界研究。
J Allergy Clin Immunol Pract. 2021 Oct;9(10):3744-3751. doi: 10.1016/j.jaip.2021.04.072. Epub 2021 May 20.